SCHEMBL30879453

SCHEMBL30879453

CCCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)[C@@H](C)CC)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCNC(=N)N)C(N)=O

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ NPY4R P50391 8/20 0.48
▸ NPY1R P25929 5/20 0.48
▸ NPY2R P49146 4/20 0.48
▸ NPY5R Q15761 4/20 0.48
▸ RXFP1 Q9HBX9 1/20 0.47
▸ KISS1R Q969F8 2/20 0.46
▸ GRIN2D O15399 1/20 0.46
▸ GRIN3B O60391 1/20 0.46
▸ GRIN1 Q05586 1/20 0.46
▸ GRIN2A Q12879 1/20 0.46
▸ GRIN2B Q13224 1/20 0.46
▸ GRIN2C Q14957 1/20 0.46
▸ GRIN3A Q8TCU5 1/20 0.46
▸ ENPEP Q07075 3/20 0.44
▸ BACE1 P56817 1/20 0.44
▸ TASP1 Q9H6P5 1/20 0.44
▸ VIPR2 P41587 3/20 0.44
▸ VIPR1 P32241 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30879458 0.95 BACE1 (0.47) NPY4RNPY1RNPY2RNPY5RRXFP1
SCHEMBL30483984 0.95 RXFP1 (0.46) NPY4RNPY1RNPY2RNPY5RRXFP1
SCHEMBL30912045 0.94 NPY4R (0.49) NPY4RNPY1RNPY2RNPY5RRXFP1
SCHEMBL30483972 0.94 ENPEP (0.49) NPY4RNPY1RNPY2RNPY5RRXFP1
SCHEMBL30912047 0.90 RXFP1 (0.49) NPY4RNPY1RNPY2RNPY5RRXFP1
SCHEMBL30912039 0.90 RXFP1 (0.50) NPY4RNPY1RNPY2RNPY5RRXFP1
SCHEMBL30912040 0.90 RXFP1 (0.50) NPY4RNPY1RNPY2RNPY5RRXFP1
SCHEMBL30912048 0.89 RXFP1 (0.50) NPY4RNPY1RNPY2RNPY5RRXFP1
SCHEMBL30912041 0.89 RXFP1 (0.48) NPY4RNPY1RNPY2RNPY5RRXFP1
SCHEMBL30912044 0.88 RXFP1 (0.49) NPY4RNPY1RNPY2RNPY5RRXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240287153-A1 Treating Inflammatory Lung Disease THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS 2024-08-29 — — US disclosed
US-20240181015-A1 EFFECT OF GHRH ANTAGONISTS IN DIABETES AND OBESITY AUGUSTA UNIVERSITY RESEARCH INSTITUTE, INC. (US) 2024-06-06 — — US disclosed
US-11993640-B2 Treating inflammatory lung disease THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS (US) 2024-05-28 — — US disclosed
Send feedback